MENU
+Compare
AMFPF
Stock ticker: OTC
AS OF
Jan 2 closing price
Price
$16.49
Change
+$0.93 (+5.98%)
Capitalization
3.5B

AMFPF stock forecast, quote, news & analysis

Amplifon SpA provides customizable hearing solutions and services through a distribution network of network affiliates, corporate shops, franchises, and shop-in-shops... Show more

AMFPF
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for AMFPF with price predictions
Jan 13, 2026

AMFPF in upward trend: 10-day moving average broke above 50-day moving average on January 12, 2026

The 10-day moving average for AMFPF crossed bullishly above the 50-day moving average on January 12, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 10 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 05, 2025. You may want to consider a long position or call options on AMFPF as a result. In of 23 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

AMFPF moved above its 50-day moving average on January 02, 2026 date and that indicates a change from a downward trend to an upward trend.

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 7 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 5 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.212) is normal, around the industry mean (9.461). P/E Ratio (27.599) is within average values for comparable stocks, (30.881). AMFPF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.588). Dividend Yield (0.020) settles around the average of (0.031) among similar stocks. P/S Ratio (1.327) is also within normal values, averaging (147.869).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. AMFPF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMFPF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock worse than average.

A.I.Advisor
published Dividends

AMFPF paid dividends on May 26, 2021

Amplifon S.p.A. AMFPF Stock Dividends
А dividend of $0.22 per share was paid with a record date of May 26, 2021, and an ex-dividend date of May 24, 2021. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are McKesson Corp (NYSE:MCK).

Industry description

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

Market Cap

The average market capitalization across the Medical Distributors Industry is 12.38B. The market cap for tickers in the group ranges from 557.05K to 102.96B. MCK holds the highest valuation in this group at 102.96B. The lowest valued company is CNBI at 557.05K.

High and low price notable news

The average weekly price growth across all stocks in the Medical Distributors Industry was 5%. For the same Industry, the average monthly price growth was 11%, and the average quarterly price growth was 28%. YI experienced the highest price growth at 75%, while COSM experienced the biggest fall at -13%.

Volume

The average weekly volume growth across all stocks in the Medical Distributors Industry was 21%. For the same stocks of the Industry, the average monthly volume growth was 2% and the average quarterly volume growth was 68%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 61
P/E Growth Rating: 57
Price Growth Rating: 50
SMR Rating: 81
Profit Risk Rating: 79
Seasonality Score: 11 (-100 ... +100)
View a ticker or compare two or three
AMFPF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry MedicalDistributors

Profile
Fundamentals
Details